Low frequency nanobubbles-enhanced noninvasive transcranial ultrasound for brain cancer therapy
This project aims to develop a novel nanobubble-mediated histotripsy technique for noninvasive glioblastoma treatment by enhancing ultrasound effects while minimizing energy requirements and off-target damage.
Projectdetails
Introduction
One of the worst diagnoses in oncology is a malignant brain tumor, with survival rates that are dismal. Noninvasive surgery can be achieved using histotripsy, a local, nonthermal ultrasound (US) surgical method that uses short, high-intensity focused US energy to mechanically ablate deep tissues through cavitation, while leaving the surrounding healthy tissues unaffected.
Current Limitations
However, brain therapy histotripsy is currently limited due to the extremely high pressures that it requires.
Proposed Solution
I propose to develop a breakthrough technology for the treatment of glioblastoma (GBM) using nanobubble (NB)-mediated transcranial histotripsy combined with blood-brain barrier (BBB) opening.
- NBs will be coupled with low-frequency US to remotely detonate cells in a manner that was not considered feasible in the past.
- As a result, low-energy, NB-mediated US surgery could be performed, reducing the required energy for standard US surgery by over an order of magnitude.
Comparison of Microbubbles and Nanobubbles
While US widely utilizes microbubbles (MBs) for intravascular ultrasonography, MBs are too big to extravasate into the tumor. Unlike MBs, NBs have a sufficiently small size for accumulation in tumors; however, it was assumed that there is a trade-off between the bubble size and its ability to obtain significant bioeffects as a result of cavitation.
Recent Findings
My recent research revealed that when a bubble is excited well below its resonance frequency, its oscillations are significantly enhanced. Thus, I hypothesize that upon accumulation within the GBM tumor, and coupled with low-frequency excitation, NBs can be used as mechanical therapeutic warheads to remotely detonate cells with minimal off-target effects.
Innovative Approach
For GBM treatment, NBs will be innovatively used for opening the BBB to allow tumor accumulation, followed by NB-mediated transcranial histotripsy.
Conclusion
This research will provide a foundational understanding of NB oscillations as an innovative tool for cancer therapy and has the potential to revolutionize the field of brain therapy.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.728.125 |
Totale projectbegroting | € 1.728.125 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- TEL AVIV UNIVERSITYpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Nanoscintillators to potentiate brain cancer radiotherapy: from physics to preclinical trialsThis project aims to enhance radiation therapy for glioblastoma by studying nanoscintillators' effects on tumor tissues, improving treatment efficacy while minimizing damage to healthy cells. | ERC Starting... | € 1.948.125 | 2024 | Details |
Preclinical in vivo validation of a glioblastoma neuro snooper electrical deviceThis project aims to develop and validate the 'GBM Neuro Snooper' device to improve understanding and treatment of glioblastoma by assessing brain electrophysiology post-tumor resection. | ERC Proof of... | € 150.000 | 2023 | Details |
Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumorsThis project aims to target the irradiated microenvironment of recurrent glioblastoma by integrating advanced sequencing methods and high-throughput screening to discover novel therapeutic strategies. | ERC Consolid... | € 1.999.444 | 2022 | Details |
Leveraging Polymer Therapeutics as Nanomedicine for Local Glioblastoma ImmunotherapyGLIOMERS aims to develop a brain-penetrating polymeric drug delivery system to enhance immunotherapy efficacy for glioblastoma by localizing treatment and stimulating antitumor immunity. | ERC Starting... | € 1.498.175 | 2025 | Details |
Trapping and Killing GlioblastomaTrapKill aims to enhance glioblastoma treatment by using a functionalized hydrogel to disrupt DNA repair mechanisms and improve the efficacy of chemo-radiotherapy. | ERC Starting... | € 1.499.938 | 2025 | Details |
Nanoscintillators to potentiate brain cancer radiotherapy: from physics to preclinical trials
This project aims to enhance radiation therapy for glioblastoma by studying nanoscintillators' effects on tumor tissues, improving treatment efficacy while minimizing damage to healthy cells.
Preclinical in vivo validation of a glioblastoma neuro snooper electrical device
This project aims to develop and validate the 'GBM Neuro Snooper' device to improve understanding and treatment of glioblastoma by assessing brain electrophysiology post-tumor resection.
Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors
This project aims to target the irradiated microenvironment of recurrent glioblastoma by integrating advanced sequencing methods and high-throughput screening to discover novel therapeutic strategies.
Leveraging Polymer Therapeutics as Nanomedicine for Local Glioblastoma Immunotherapy
GLIOMERS aims to develop a brain-penetrating polymeric drug delivery system to enhance immunotherapy efficacy for glioblastoma by localizing treatment and stimulating antitumor immunity.
Trapping and Killing Glioblastoma
TrapKill aims to enhance glioblastoma treatment by using a functionalized hydrogel to disrupt DNA repair mechanisms and improve the efficacy of chemo-radiotherapy.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy. | EIC Pathfinder | € 5.972.875 | 2024 | Details |
Closed-loop Individualized image-guided Transcranial Ultrasonic StimulationThe project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders. | EIC Pathfinder | € 3.799.402 | 2022 | Details |
Clinical validation of NANO-PL: a hydrogel-based formulation of a small molecule for a highly targeted therapy against Glioblastoma Multiforme (GBM)NANO-PL is a hydrogel-based, one-time treatment for glioblastoma that shows promising safety and efficacy, including tumor eradication and improved survival rates in preclinical models. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Transforming brain surgery by advancing functional-guided neuronavigational imagingHyperProbe is an innovative all-optical imaging system using hyperspectral imaging and AI to enhance intraoperative neuronavigation and biomarker analysis during brain tumor surgeries. | EIC Pathfinder | € 3.360.825 | 2022 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy.
Closed-loop Individualized image-guided Transcranial Ultrasonic Stimulation
The project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders.
Clinical validation of NANO-PL: a hydrogel-based formulation of a small molecule for a highly targeted therapy against Glioblastoma Multiforme (GBM)
NANO-PL is a hydrogel-based, one-time treatment for glioblastoma that shows promising safety and efficacy, including tumor eradication and improved survival rates in preclinical models.
Transforming brain surgery by advancing functional-guided neuronavigational imaging
HyperProbe is an innovative all-optical imaging system using hyperspectral imaging and AI to enhance intraoperative neuronavigation and biomarker analysis during brain tumor surgeries.
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.